DIFFERENTIAL PRIMING TO PROGRAMMED CELL-DEATH OF SUPERANTIGEN-REACTIVE LYMPHOCYTES OF HIV PATIENTS

被引:9
作者
GORLA, R
IMBERTI, L
PRATI, E
BRUGNONI, D
CALIGARIS, S
CATTANEO, R
ALBERTINI, A
PRIMI, D
机构
[1] UNIV BRESCIA,DEPT CHEM,CNR,CONSORZIO BIOTECNOL,I-25123 BRESCIA,ITALY
[2] SPEDALI CIVILI BRESCIA,CLIN IMMUNOL UNIT,I-25123 BRESCIA,ITALY
[3] SPEDALI CIVILI BRESCIA,TERZO SERV ANAL,I-25123 BRESCIA,ITALY
[4] SPEDALI CIVILI BRESCIA,DEPT INFECT DIS,I-25123 BRESCIA,ITALY
关键词
D O I
10.1089/aid.1994.10.1097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed cell death or apoptosis has been shown to play a central role in CD4(+) T cell depletion following HIV infection. Because most apoptotic signals are delivered through T cell receptor stimulation, we investigated whether T cell depletion in AIDS is a stochastic phenomenon or if it preferentially affects T cell subsets defined by their interaction with superantigens. To address this problem we have taken advantage of the exclusive property of superantigens to trigger T cells expressing selective sets of T cell receptor V beta elements. Here we report that CD4(+) T cells from HIV-infected patients can proliferate in vitro to T cell receptor mobilization by some superantigens, but not others. Furthermore, the failure of T cells to respond to some superantigens was shown to be due to an active cell death process that differentially affected T cells capable of interacting with different superantigens. The selective programmed cell death priming of T cells responsive to particular superantigens, observed in this study, suggests that T cell depletion in HIV infection is not simply due to the cytopathic effect of the virus. The possible link between programmed cell death and T cell receptor variable regions suggested by the present experiments may help to better define current models of AIDS pathogenesis.
引用
收藏
页码:1097 / 1103
页数:7
相关论文
共 47 条
[1]  
AMADORI A, 1989, J IMMUNOL, V143, P2146
[2]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[3]   T-CELLS, V-GENES, AND HIV [J].
BANSAL, AS ;
GREEN, LM ;
PUMPHREY, RSH ;
MANDAL, B .
LANCET, 1992, 339 (8809) :1604-1604
[4]   V-BETA-17 GENE POLYMORPHISM IN WILD-DERIVED MOUSE STRAINS - 2 AMINO-ACID SUBSTITUTIONS IN THE V-BETA-17 REGION GREATLY ALTER T-CELL RECEPTOR SPECIFICITY [J].
CAZENAVE, PA ;
MARCHE, PN ;
JOUVINMARCHE, E ;
VOEGTLE, D ;
BONHOMME, F ;
BANDEIRA, A ;
COUTINHO, A .
CELL, 1990, 63 (04) :717-728
[5]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[6]   SUPERANTIGENS AND ENDOGENOUS RETROVIRUSES - A CONFLUENCE OF PUZZLES [J].
COFFIN, JM .
SCIENCE, 1992, 255 (5043) :411-413
[7]   SELECTIVE ANERGY OF V-BETA-8(+) T-CELLS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS [J].
DADAGLIO, G ;
GARCIA, S ;
MONTAGNIER, L ;
GOUGEON, ML .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :413-424
[8]   T-CELL RECEPTOR VARIABLE GENE-PRODUCTS AND EARLY HIV-1 INFECTION [J].
DALGLEISH, AG ;
WILSON, S ;
GOMPELS, M ;
LUDLAM, C ;
GAZZARD, B ;
COATES, AM ;
HABESHAW, J .
LANCET, 1992, 339 (8797) :824-828
[9]   ANTI-LYMPHOCYTE ANTIBODIES IN PATIENTS WITH THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].
DORSETT, B ;
CRONIN, W ;
CHUMA, V ;
IOACHIM, HL .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (04) :621-626
[10]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362